PTGS2 and cholangiocarcinoma: Previously, the COX-2 inhibitors JTE-522 and NS-398 were shown to inhibit cell growth in 5 human COX-2-expressiing CCA cell lines at concentrations of 100 μM and 200 μM, respectively [12].